↓ Skip to main content

Resensitization to Crizotinib by the LorlatinibALKResistance Mutation L1198F

Overview of attention for article published in New England Journal of Medicine, January 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
9 news outlets
twitter
166 tweeters
facebook
6 Facebook pages

Citations

dimensions_citation
262 Dimensions

Readers on

mendeley
279 Mendeley